Dr David Andrew Arlwydd Owen
Dr David Andrew Arlwydd Owen was appointed in a total of 6 companies and resigned from 6 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
British
Date of Birth
February 1944
Occupation
Business Consultant
Active
0
Resigned
6
Dissolved
0
Other
0
Total
6
Companies
| Company | Timeline | Status | |
| Oxford Gene Technology (Southern) Limited Director • Director | 10 Mar 2009←13 Years→31 Oct 2022 | Active | |
| Biodexa Pharmaceuticals (Wales) Limited Director • Director | 20 Feb 2006←1 Year 2 Months→30 Apr 2007 | Active | |
Sepal Pharma Plc Director • Business Consultant | 30 Jan 2006←3 Years→8 Jan 2010 | Dissolved | |
| Oxford Gene Technology Ip Limited Director • Director | 7 Sep 2005←17 Years→31 Oct 2022 | Active | |
| Oxford Gene Technology (Operations) Ltd Director • Director | 7 Sep 2005←17 Years→31 Oct 2022 | Active | |
| Oxford Gene Technology Limited Director • Director | 7 Sep 2005←17 Years→31 Oct 2022 | Active | |
Mutual People
- DR Michael Robert EvansOxford Gene Technology (Operations) Ltd, Oxford Gene Technology Ip Limited, Oxford Gene Technology (Southern) Limited, and 1 more are mutual companies.
- Dr Sonia MorganOxford Gene Technology Ip Limited, Oxford Gene Technology (Operations) Ltd, Oxford Gene Technology (Southern) Limited, and 1 more are mutual companies.
- Anthony John LenhardtOxford Gene Technology Limited, Oxford Gene Technology Ip Limited, Oxford Gene Technology (Southern) Limited, and 1 more are mutual companies.
- Dr Timothy CookOxford Gene Technology (Operations) Ltd, Oxford Gene Technology Ip Limited, Oxford Gene Technology (Southern) Limited, and 1 more are mutual companies.
- Professor Edwin Mellor SouthernOxford Gene Technology (Operations) Ltd, Oxford Gene Technology Ip Limited, Oxford Gene Technology Limited, and 1 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
